investig
cytolog
specimen
obtain
aspir
fna
least
invas
approach
obtain
diagnosi
cytomorpholog
howev
provid
limit
insight
biolog
neoplast
disord
etiolog
infecti
process
may
necessari
combin
cytomorpholog
specif
diseas
marker
elucid
underli
diseas
collect
predict
contrast
histolog
investig
allow
multipl
tissu
section
examin
individu
cell
repetit
impress
smear
fna
tissu
mean
reproduc
composit
cell
tissu
addit
technolog
limit
type
distribut
lesion
pose
essenti
limit
holist
cytolog
character
thu
detect
compromis
lesion
poorli
exfoli
low
cellular
b
affect
tissu
difficult
access
eg
central
nervou
system
cn
compris
spars
fluid
eg
cerebrospin
fluid
csf
c
atyp
cell
pathogen
poorli
dens
scantli
distribut
cell
highli
vulner
shear
stress
detect
chang
sampl
low
cellular
multipl
investig
carri
slide
rather
singl
investig
multipl
slide
variabl
cell
number
simplest
secondari
procedur
use
convent
stain
highlight
microorgan
chemic
compound
matrix
compon
subcellular
structur
histochemistri
destain
procedur
advanc
panopt
stain
special
stain
mainli
focus
assess
microbi
fungal
organ
eg
gram
mucin
polysaccharid
eg
alcian
blue
period
iron
pigment
melanin
eg
prussian
blue
reaction
nile
blue
cellular
identif
rare
need
situat
ancillari
stain
often
conduct
spare
infecti
diseas
tumor
cell
antigen
howev
could
requir
preselect
cytomorpholog
character
cell
hold
true
particular
advanc
tumor
immunocytochemistri
icc
prestain
slide
poststain
icc
psicc
could
help
identifi
histogenet
origin
tumor
cell
type
character
cell
identifi
convent
stain
obtain
prognost
predict
infecti
diseas
psicc
promis
tool
intracellular
detect
viral
protein
one
common
situat
detect
felin
coronaviru
fcov
diagnosi
felin
infecti
periton
fip
presenc
intracellular
viral
antigen
macrophag
must
approach
requir
preserv
target
antigen
host
cell
morpholog
histor
psicc
methodolog
tailor
individu
case
therefor
systemat
studi
reproduc
efficaci
reliabl
immunostain
henc
present
studi
aim
fill
gap
establish
reproduc
guidelin
psicc
label
select
cellular
viral
antigen
tissu
imprint
fna
cytocentrifug
fluid
focu
specif
antigen
preserv
retriev
target
antigen
select
driven
daili
neurocytolog
specimen
caseload
variou
mammalian
speci
possibl
inflammatori
infecti
cn
diseas
studi
investig
abil
appli
icc
prestain
cytolog
specimen
b
whether
coverslip
could
use
preserv
antigen
c
whether
microwav
treatment
mwt
enhanc
immunodetect
prestain
smear
therefor
icc
stain
qualiti
evalu
smear
prestain
modifi
wright
stain
modw
destain
hydrochlor
acid
hcl
compar
unstain
sampl
without
coverslip
mwt
effect
evalu
set
cellular
antigen
distinct
subcellular
distribut
studi
intracellular
fcov
protein
studi
b
procedur
carri
institut
veterinari
patholog
lmu
munich
investig
enrol
surplu
postmortem
sampl
studi
b
andor
discard
specimen
studi
b
examin
complet
diagnosi
achiev
procedur
exempt
institut
anim
care
use
committe
review
decid
ethic
commiss
centr
veterinari
clinic
medicin
lmu
munich
test
impact
individu
pretreat
immunostain
nuclear
cytoplasm
membran
antigen
therefor
systemat
evalu
employ
distinct
methodolog
trial
illustr
figur
tabl
seri
impress
smear
fna
prepar
taken
brain
lymph
node
cat
pig
postmortem
examin
hour
euthanasia
reason
unrel
studi
purpos
cn
cell
obtain
postcruci
gyru
brain
extens
craniectomi
encephalectomi
trim
describ
sampl
collect
superfici
cervic
lymph
node
via
fna
use
syring
prepar
immedi
set
cytolog
smear
cn
fna
stain
cytomorpholog
examin
trial
use
hematek
slide
stainer
siemen
healthcar
diagnost
inc
tarrytown
ny
usa
anoth
slide
per
antigen
stain
modifi
wright
stain
modw
coverslip
use
mount
medium
histokitt
glaswarenfabrik
karl
hecht
gmbh
co
kg
germani
underw
hot
mount
polymer
use
mwt
minut
w
dri
prior
psicc
tabl
slide
coverslip
least
day
effect
cycl
sd
slide
immunodetect
trial
plu
addit
effect
addit
cycl
slide
trial
investig
anoth
slide
trial
compar
slide
trial
seri
slide
subject
treatment
serv
gold
standard
trial
tabl
sampl
store
month
slide
except
trial
subject
laboratori
treatment
mention
preced
icc
coverslip
sampl
trial
immers
xylen
achiev
liquefact
mount
medium
coverslip
slip
thereaft
slide
put
grade
ethanol
seri
minut
immers
distil
water
prestain
decoverslip
slide
trial
left
uncov
modw
method
trial
immers
hcl
color
complet
fade
identifi
microscopi
freshli
destain
slide
trial
nonstain
decoverslip
slide
trial
immers
distil
water
icc
perform
figur
tabl
perform
icc
one
set
slide
trial
trial
n
trial
n
figur
tabl
subject
antigen
retriev
procedur
slide
transfer
cuvett
contain
moll
citrat
buffer
solut
ph
base
immunohistochem
protocol
mwt
carri
w
follow
w
slide
left
citrat
buffer
minut
cool
room
temperatur
step
except
primari
antibodi
pab
incub
carri
room
temperatur
mwt
slide
kept
distil
water
destain
unstain
slide
without
mwt
tabl
bath
moll
salin
pb
ph
minut
endogen
peroxidas
quench
minut
ad
hydrogen
peroxid
pb
thereaft
slide
wash
fresh
pb
transfer
humidifi
chamber
incub
normal
goat
serum
mp
biomed
llc
hutton
center
drive
santa
ana
ca
usa
minut
upon
remov
nonimmun
serum
lymph
node
fna
incub
antibodi
detect
correspond
cell
antigen
marker
specif
neun
gfap
use
separ
brain
smear
tabl
run
contain
slide
pab
replac
antibodi
diluent
serv
neg
control
altogeth
n
incub
carri
hour
repeat
wash
step
pb
slide
mount
biotinyl
goat
igg
antibodi
dako
glostrup
denmark
hour
bound
pab
subsequ
visual
use
abc
amplif
kit
vectastain
vector
laboratori
inc
burlingam
ca
usa
use
diaminobenzidin
tetrahydrochlorid
dab
chromagen
enzym
reaction
block
pb
rins
slide
counterstain
mayer
hematoxylin
applichem
gmbh
darmstadt
germani
underw
ascend
ethanol
seri
coverslip
describ
cell
yield
preserv
assess
bright
field
microscopi
two
differ
clinic
pathologist
separ
session
observ
blind
smear
origin
pretreat
type
pab
type
evalu
icc
outcom
icc
qualiti
determin
cell
type
specif
b
intens
cellular
stain
c
presenceabs
acellular
background
activ
nonspecif
stain
paramet
semiquantit
score
use
system
event
intraobserv
disagr
slide
review
multihead
microscop
zeiss
axiophot
carl
zeiss
ag
oberkochen
germani
mean
valu
newli
assign
statist
evalu
final
score
compar
differ
procedur
use
nonparametr
statist
algorithm
p
indic
statist
signific
studi
evalu
impact
pretreat
fcov
antigen
immunolabel
studi
b
conduct
pleural
n
abdomin
n
effus
fip
case
confirm
histopatholog
fcov
effus
collect
use
convent
thoracentesi
abdominocentesi
procedur
harvest
fluid
mount
onto
uncoat
standard
slide
langenbrinck
emmendingen
germani
use
cytocentrifug
hettich
univers
adelsri
germani
accord
protocol
effus
centrifug
chamber
spun
minut
supernat
remov
coat
slide
centrifug
minut
slide
store
process
evalu
preserv
antigen
viral
antigen
sampl
underw
trial
without
mwt
describ
studi
icc
perform
use
mous
monoclon
antibodi
direct
coronaviru
nucleocapsid
clone
tabl
incub
subsequ
step
ident
appli
neun
label
see
use
abc
enhanc
dab
icc
signal
observ
concern
cellular
subcellular
local
intens
specif
background
describ
evalu
cell
preserv
slide
microscop
assess
slide
reveal
repres
cell
yield
fewer
cell
suffer
crush
artifact
fewer
ghost
nuclei
cell
preserv
invers
relat
cell
size
lymphocyt
glial
cell
small
granul
neuron
less
vulner
shear
forc
larg
neuron
sampl
coverslip
least
day
time
need
coverslip
remov
upon
immers
xylen
correspond
durat
sinc
coverslip
slide
coverslip
fewer
day
coverslip
remov
within
hour
incub
slide
coverslip
week
need
day
remov
coverslip
without
manipul
effect
destain
hcl
assess
microscop
thin
fna
smear
requir
minut
achiev
complet
decolor
thick
brain
smear
requir
hcl
treatment
minut
complet
bleach
observ
independ
blood
content
endogen
peroxidas
activ
complet
remov
quench
slide
minut
seen
control
subject
direct
dab
treatment
among
unstain
noncoverslip
specimen
trial
n
icc
marker
provid
good
reliabl
reproduc
result
high
intens
median
intens
score
high
cell
specif
median
cell
specif
score
css
absent
neun
low
background
signal
gfap
score
figur
tabl
gfap
background
brownish
cloudi
sometim
floccul
stain
evid
specimen
tabl
howev
background
interfer
distinct
stain
astrocyt
somata
regard
subcellular
distribut
icc
plain
slide
signal
strongest
peripheri
lymphocyt
cytoplasm
close
membran
neun
immunoreact
restrict
neuron
nuclei
gfap
diffus
stain
soma
fragment
process
astrocyt
even
coverslip
decoverslip
cdc
trial
icc
permit
identif
three
cell
type
figur
howev
stain
intens
cell
specif
neun
specimen
significantli
lower
observ
trial
p
gfap
background
stain
stronger
p
tabl
sd
trial
interfer
immunolabel
icc
perform
within
day
romanowski
stain
howev
delay
week
abolish
immunolabel
significantli
figur
henc
detect
marker
sever
compromis
cell
specif
p
intens
p
tabl
weak
cellular
stain
seen
isol
lymphocyt
astrocyt
major
cell
specimen
remain
immunoneg
earli
coverslip
specimen
trial
rescu
antigen
three
antigen
compar
prestain
noncoverslip
slide
trial
intens
cell
specif
p
figur
tabl
specif
signal
obtain
slide
median
signal
intens
si
tabl
nonspecif
background
stain
restrict
mostli
gfap
slide
remain
distinct
cellular
chromagen
enrich
seen
figur
tabl
notabl
sdscdc
affect
subcellular
distribut
immunostain
signal
extend
throughout
lymphocyt
cytoplasm
rather
accentu
peripheri
gfap
stain
astrocyt
leak
nucleu
neun
stain
still
mainli
confin
neuron
nuclei
howev
signal
patchi
encompass
entir
nuclear
area
figur
hot
mount
coverslip
impact
icc
result
p
mwt
citrat
buffer
significantli
increas
si
cell
specif
marker
p
figur
tabl
therefor
neg
effect
sd
exacerb
marker
gfap
immunostain
trial
becam
even
stronger
plain
slide
si
p
css
p
neun
si
p
css
p
gfap
si
p
css
p
posit
effect
mwt
restrict
coverslip
slide
omiss
coverslip
trial
fail
rescu
antigen
type
chemic
pretreat
trial
complet
abolish
immunostain
fcov
nucleocapsid
figur
b
tabl
therefor
contrast
immunodetect
cellular
antigen
coverslip
protect
viral
antigen
stain
slide
tabl
likewis
mwt
preclud
immunostain
plain
slide
trial
henc
fail
rescu
antigen
label
pretreat
slide
accord
rose
concept
rapid
evalu
cytolog
examin
valuabl
tool
establish
definit
tissu
diagnosi
practic
complement
histolog
studi
reveal
previous
unrecogn
howev
enorm
demand
specif
diagnos
confirm
specifi
atyp
rare
infect
undifferenti
special
stain
recommend
perform
parallel
routin
smear
evalu
use
separ
unstain
clinic
set
howev
exploit
avail
test
often
limit
pauciti
slide
poor
sampl
preserv
low
cellular
blood
contamin
differ
yield
cell
composit
among
consecut
limit
relev
poorli
access
tissu
eg
cn
media
csf
pericardi
effus
procedur
inflict
high
procedur
morbid
eg
involv
heart
lung
cn
diagnostician
often
must
cope
scenario
sequenti
test
carri
slide
could
provid
subcellular
molecular
metabol
detail
context
sampl
ideal
best
cytolog
sampl
exhibit
conspicu
chang
subject
addit
test
way
cytolog
context
preserv
inform
obscur
concomit
nonrelev
cell
contamin
blood
cell
previou
studi
case
report
demonstr
feasibl
subject
cytolog
histolog
histochem
stain
slide
immunocytochemistri
situ
hybrid
procedur
second
studi
mainli
carri
remov
previou
dye
alcohol
bleach
hydrogen
chlorid
appli
mwt
citrat
buffer
distil
investig
perform
direct
immunolabel
nuclear
cytoplasm
membran
antigen
neoplast
tissu
smear
previous
stain
papanicola
giemsa
stain
subject
stain
remov
romanowski
stain
bind
cell
compon
electrostat
forc
without
caus
conform
chang
target
thu
giemsapappenheim
hemacolor
seen
studi
modifi
wright
stain
exhibit
low
risk
interfer
immunodetect
appear
howev
lag
period
cytolog
stain
immunolabel
critic
determin
publish
psicc
studi
document
success
immunostain
time
period
much
year
notabl
slide
coverslip
cytolog
stain
icc
even
absenc
cytolog
stain
antigen
therefor
immunoreact
report
decreas
week
without
longer
preserv
need
recommend
store
slide
seen
studi
even
cytolog
stain
appear
acceler
decay
immunoreact
week
immunoposit
cellular
marker
decreas
significantli
similar
experi
mention
immedi
coverslip
shield
vulner
stain
film
detriment
environment
factor
studi
show
decay
antigen
directli
associ
exposur
dye
destain
procedur
compar
unstain
coverslip
slide
without
coverslip
ionic
dye
compon
appear
facilit
cellular
biomolecul
degrad
oxid
stress
less
known
slide
seal
lid
use
mount
medium
decreas
antigen
significantli
lower
still
identifi
howev
initi
immunoreact
level
fresh
plain
slide
could
reestablish
previous
stain
slide
underw
mwt
citrat
buffer
decoverslip
destain
rehydr
tradit
mwt
use
immunohistochemistri
tissu
antigen
recoveri
aldehyd
similarli
mwt
proven
use
antigen
demask
cytolog
specimen
fixat
ethanol
cytolog
howev
mwt
fail
recov
viral
antigen
detect
studi
instead
mwt
alon
effect
abolish
immunolabel
fcov
untreat
unstain
film
furthermor
possibl
reestablish
immunostain
anteced
cytolog
stain
coverslip
thu
fcov
epitop
appear
much
vulner
chang
induc
physicochem
factor
cellular
protein
investig
studi
whether
viral
antigen
preserv
achiev
prior
fixat
smear
describ
microbi
antigen
current
investig
studi
propos
fixat
formalin
ethanol
improv
icc
even
though
observ
made
substatist
number
sampl
studi
result
provid
evid
viral
antigen
label
icc
sensit
interfer
laboratori
procedur
cellular
antigen
label
consequ
liabil
consid
test
icc
carri
spars
sampl
volum
summari
psicc
easi
sensit
reliabl
reproduc
method
immedi
evalu
select
marker
cell
cytolog
stain
hand
rapidli
decreas
antigen
left
uncoverslip
cellular
antigen
decay
counteract
perform
mwt
prior
immunolabel
viral
epitop
howev
might
requir
dedic
preserv
techniqu
studi
pretreat
abolish
icc
result
fcov
detect
prestain
film
